Insecticides (India) Limited has informed the Exchange about Formulation of Employee Stock Purchase Scheme 2026 ( IIL ESPS Scheme 2026 or Scheme )
INSECTICID · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Insecticides (India) Limited reported FY26 standalone revenue of Rs 2,00,949 lakhs, up 39% from Rs 1,44,628 lakhs in FY25. Profit after tax remained flat at Rs 13,975 lakhs versus Rs 13,971 lakhs. The Board approved the Employee Stock Purchase Scheme 2026 (IIL ESPS Scheme) allowing up to 2,00,000 equity shares for employees, subject to shareholder approval at the 29th AGM. Mrs. Nikunj Aggarwal resigned as Whole Time Director and Mr. Sanskar Aggarwal was appointed as Whole Time Director (Additional). Joint statutory auditors gave an unmodified (clean) opinion on the financial statements.
Strong revenue growth of 39% is offset by flat profitability, suggesting margin pressures. The new ESPS scheme aligns employee interests with shareholders but will dilute equity. The leadership transition to a family member (Sanskar Aggarwal) may signal succession planning within the promoter family.